GM2 ganglioside as a regulator of pyramidal neuron dendritoenesis

Annals of the New York Academy of Sciences

Volumn 845, Issue , 1998, Pages 188-199

  Walkley, Steven U ^a   Siegel, Donald A ^a   Dobrenis, Kostantin ^a   Zervas, Mark ^a  

^a New York State Office of Mental Retardation and Developmental Disabilities   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE GM2;

BRAIN CORTEX; BRAIN DEVELOPMENT; CONFERENCE PAPER; DENDRITE; HUMAN; NERVE MEMBRANE; NERVE SPROUTING; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PERIKARYON; PYRAMIDAL NERVE CELL; TAY SACHS DISEASE;

MAMMALIA;

EID: 0031905046     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb09671.x     Document Type: Article

References (62)

1. JACOBSEN, M. 1991. Developmental Neurobiology, 3rd ed.
2. MARIN-PADILLA, M. 1992. Ontogenesis of the pyramidal cell of the mammalian neocortex and developmental cytoarchitectonics: A unifying theory. J. Comp. Neurol. 321: 233- 240.
3. BUELL, S. & P. COLEMAN. 1979. Dendritic growth in the aged human brain and failure of growth in senile dementia. Science 206: 854-856.
4. PURPURA, D. P. & K. SUZUKI. 1976. Distortion of neuronal geometry and formation of aberrant synapses in neuronal storage disease. Brain Res. 116: 1-21.
5. PURPURA, D. P. 1978. Ectopic dendritic growth in mature pyramidal neurones in human gagliosdie storage disease. Nature 276: 520-521.
6. PURPURA, D. P. 1974. Dendritic spine "dysgenesis" and mental retardation. Science 186: 1125-1128.
7. BLACKWOOD, W. & J. A. N. CORSELLIS. 1976. Greenfield's Neuropathology, 3rd ed.
8. WALKLEY, S. U. 1988. Pathobiology of neuronal storage disease. Int. Rev. Neurobiol. 29: 191-244.
9. JOLLY, R. D. & S. U. WALKLEY. 1997. Lysosomal storage diseases of animals: An essay in comparative pathology. Vet. Pathol. 34: 527-548.
10. DORLING, P. R., S. M. COLEGATE, & C. R. HUXTABLE. 1989. Swainsonine: A toxic indolizidine alkaloid. In Toxicants of Plant Origin, Vol. I: Alkaloids, P.R. Cheeke, Ed.: 237-256.
11. WALKLEY, S. U. & D. A. SIEGEL. 1989. Comparative studies of the CNS in swainsonineinduced and inherited feline α-mannosidosis. In Swainsonine and Related Glycosidase Inhibitors, L. F. James, A. D. Elbein, R. J. Molyneux, and C. D. Warren, Eds.: 57-75. Iowa State Univ. Press. Ames.
12. WALKLEY, S. U, M. E. HASKINS & R. M. SHULL. 1988. Alterations in neuron morphology in mucopolysaccharide storage disorders. Acta Neuropathol. 75: 611-620.
13. WALKLEY, S. U. & H. J. BAKER. 1984. Sphingomyelin lipidosis in a cat. II. Golgi studies. Acta Neuropathol. 65: 138-144.
14. MARCH, P. A., M. A. THRALL, D. E. BROWN, T. W. MITCHELL, A. C. LOWENTHAL & S. U. WALKLEY. 1997. GABAergic neuroaxonal dystrophy and other cytopathological alterations in feline Niemann-Pick disease type C. Acta Neuropathol. In press.
15. WALKLEY, S. U, W. F. BLAKEMORE & D. P. PURPURA. 1982. Alterations in neuron morphology in feline mannosidosis: A Golgi study. Acta Neuropathol. 53: 75-79.
16. WALKLEY, S. U., D. A. SIEGEL & S. WURZELMANN. 1988. Ectopic dendritogenesis and associated synapse formation in swainsonine-induced neuronal storage disease. J. Neurosci. 8: 445-457.
17. WALKLEY, S. U. & S. WURZELMANN. 1995. Alterations in synaptic connectivity in cerebral cortex in neuronal storage diseases. Ment. Retard. Dev. Disabil. Res. Rev. 1: 183-192.
18. WALKLEY, S. U., S. WURZELMANN & D. P. PURPURA. 1981. Ultrastructure of neuntes and meganeurites of cortical pyramidal neurons in feline gangliosidosis as revealed by the combined Golgi-EM technique. Brain Res. 211: 393-398.
19. WALKLEY, S. U, S. WURZELMANN, M. C. RATTAZZI & H. J. BAKER. 1990. Distribution of ectopic neurite growth and other geometrical distortions of neurons in feline GM2 ganglioisdosis. Brain Res. 510: 63-73.
20. WALKLEY, S. U, H. J. BAKER & M. C. RATTAZZI. 1990. Initiation and growth of ectopic neurties and meganeurites during postnatal brain development in ganglioside storage disease. Dev. Brain Res. 51: 167-178.
21. WALKLEY, S. U., S. WURZELMANN & D. A. SIEGEL. 1987. Ectopic axon hillock-associated neurite growth is maintained in metabolically reversed swainsonine-induced neuronal storage disease. Brain Res. 410: 89-96.
22. GOODMAN, L. A., P. O. LIVINGSTON & S. U. WALKLEY. 1991. Ectopic dendrites occur only on cortical pyramidal cells containing elevated GM2 ganglioside in ct-mannosidosis. Proc. Natl. Acad. Sci. USA 88: 11330-11334.
23. WALKLEY, S. U. 1995. Pyramidal neurons with ectopic dendrites in storage diseases contain elevated levels of GM2 ganglioside. Neurosci. 68: 1027-1035.
24. SIEGEL, D. A. & S. U. WALKLEY. 1994. Growth of ectopic dendrites on cortical pyramidal neurons in neuronal storage diseases correlates with abnormal accumulation of GM2 ganglioside. J. Neurochem. 62: 1852-1862.
25. NOBACK, C. R. & D. P. PURPURA. 1962. Postnatal ontogenesis of neurons in cat neocortex. J. Comp. Neurol. 117: 291-307.
26. MARIN-PADILLA, M. 1972. Prenatal ontogenetic history of the principal neurons of the neocortex of the cat (Felis domestica). A Golgi study. Z. Anat. Entwickl.-Gesch. 136: 125-142.
27. GOODMAN, L. & S. U. WALKLEY. 1996. Elevated GM2 ganglioside is associated with dendritic proliferation in normal developing neocortex. Dev. Brain Res. 93: 162-171.
28. WALKLEY, S. U, D. A. SIEGEL & K. DOBRENIS. 1995. GM2 ganglioside and pyramidal neuron dendritogenesis. Neurochem. Res. 20: 1287-1299.
29. LEDEEN, R. W. 1985. Biology of gangliosides: Neuritogenic and neuronotrophic properties. In Neurobiology of Gangliosides, A. Gorio and B. Haber, Eds.: 147-159. Alan R. Liss. New York.
30. YUSUF, H. K. M., G. POHLENTZ & K. SANDHOFF. 1984. Ganglioside biosynthesis in Golgi apparatus: New perspectives on its mechanism. J. Neurosci. Res. 12: 161-178.
31. SANDHOFF, K. & G. SCHWARZMANN. 1989. Dynamics of gangliosides in neuronal membranes. In Progress in Zoology Vol. 37, Fundamentals of Memory Formation; Neuronal Plasticity, and Brain Function, H. Rahmann, Ed.: 229-239. VCH. New York.
32. SANDHOFF, K. & A. KLEIN. 1994. Intracellular trafficking of glycosphingolipids: Role of sphingolipid activator proteins in the topology of endocytosis and lysosomal digestion. FEES Lett. 346: 103-107.
33. SCHWARZMANN, G. & K. SANDHOFF. 1990. Metabolism and intracellular transport of glycosphingolipids. Biochemistry 29: 10865-10871.
34. SANDHOFF, K. & G. ECHTEN. 1994. Ganglioside metabolism: Enzymology, topology, and regulation. Prog. Brain Res. 101: 17-30.
35. Yu, R. K. 1994. Developmental regulation of ganglioside metabolism. Prog. Brain Res. 101: 31-44.
36. SUZUKI, K. 1995. The pattern of mammalian brain gangliosides III. Regional and developmental differences. J. Neurochem. 12: 969-979.
37. TETTAMANTI, G. 1971. Brain gangliosides in development. Adv. Exp. Med. Biol. 13: 75-89.
38. VANIER, M., M. HOLM, R. OIIMAN & L. SVENNERHOLM. 1971. Developmental profiles of gangliosides in human and rat brain. J. Neurochem. 18: 581-592.
39. SCHENGRUND, C. A. 1990. The role(s) of gangliosides in neuronal differentiation and repair: A perspective. Brain Res. Bull. 24: 131-141.
40. SKAPER, S. D., A. LEON & G. TOFFANO. 1989. Ganglioside function in the development and repair of the nervous system. Mol. Neurobiol. 3: 173-199.
41. YATES, A. J. 1986. Gangliosides in the nervous system during development and regeneration. Neurochem. Pathol. 5: 309-329.
42. SANDHOFF, K. & T. KOLTER. 1996. Topology of glycosphingolipid degradation. Trends Cell Biol. 6: 98-103.
43. D2, Gangliosides. J. Biol. Chem. 267: 12082-12089.
44. YAMAMOTO, A., M. HARAGUCHI, S. YAMASHIRO, S. FUKUMOTO, K. FURUKAWA, K. TAKAMIYA, M. ATSUTA, H. SHIKU & K. FURUKAWA. 1996. Heterogeneity in the expression pattern of two ganglioside synthase genes during mouse brain development. J. Neurochem. 66: 26-34.
45. Yu, R. K., L. J. MACALA, T. TAKI, H. M. WINFIELD & F. S. Yu. 1988. Developmental changes in ganglioside composition and synthesis in embryonic rat brain. J. Neurochem. 50: 1825-1829.
46. IRIE, R. F. 1980. In Serologie Analysis of Human Cancer Antigens, S. Rosenberg, Ed.: 493-513. Academic Press, New York.
47. TAI, T, J. C. PAULSON, L. D. CAHAN & R. F. IRIE. 1983. Ganglioside GM2 as a human tumor antigen (OFA-I-1). Proc. Natl. Acad. Sci. USA 80: 5392-5396.
48. HAKOMORI, S. I. 1990. Bifunctional role of glycosphingolipids. J. Biol. Chem. 265: 18713-18716.
49. HAKOMORI, S. 1995. Role of gangliosides in transmembrane signaling and cell recognition. In Biology of the Sialic Acids, A. Rosenberg, Ed.: 243-259. Plenum Press. New York.
50. HYNDS, D. L., M. SUMMERS, J. VAN BROCKLYN, M. S. O'DoRisio & A. J. YATES. 1995. Gangliosides inhibit platlet-derived growth factor-stimulated growth, receptor phosphorylation, and dimerization in neuroblastoma SH-SY5Y cells. J. Neurochem. 65: 2251-2258.
51. LACETTI, P., D. TOMBACCINI, S. ALOJ, E. F. GROLLMAN & L. KOHN. 1984. Gangliosides, the thyrotropin receptor, and autoimmune thyroid disease. Adv. Exp. Med. Biol. 174: 355-367.
52. FERRARI, G., B. L. ANDERSON, R. M. STEPHENS, D. R. KAPLAN & L. A. GREENE. 1995. Prevention of apoptotic neuronal death by GMI ganglioside. J. Biol. Chem. 270: 3074-3080.
53. MUTOII, T, A. TOKUDA, T. MIYADAI, M. HAMAGUCHI & N. FUJIKI. 1995. Ganglioside GMI binds to the TRK protein and regulates receptor function. Proc. Natl. Acad. Sci. USA 92: 5087-5091.
54. WADA, L, W. H. LAI, B. I. POSNER & J. J. M. BERGERON. 1992. Association of the tyrosine phosphorylated epidermal growth factor receptor with 55-kd tyrosine phosphorylated protein at the cell surface and in endosomes. J. Cell. Biol. 116: 321-330.
55. BEVAN, A. P., P. G. DRAKE, J. J. M. BERGERON & B. I. POSNER. 1996. Intracellular signal transduction: The role of endosomes. TEM 7: 13-21.
56. NIXON, R. A. & A. M. CATALDO. 1995. The endosomal-Iysosomal system of neurons: New roles. Trends Neurosci. 18: 489-496.
57. MATTSON, M. P. 1988. Neurotransmitters in the regulation of neuronal cytoarchitecture. Brain Res. Rev. 13: 179-212.
58. HAUSER, K. F., P. J. MCLAUGHLIN & I. S. ZAGON. 1989. Endogenous opioid systems and the regulation of dendritic growth and spine formation. J. Comp. Neurol. 281: 13-22.
59. McALLISTER, A. K., D. C. Lo & L. C. KATZ. 1995. Neurotrophins regulate dendritic growth in developing visual cortex. Neuron 15: 791-803.
60. MCALLISTER, A. K., L. C. KATZ & D. C. Lo. 1996. Neurotrophin regulation of cortical dendritic growth requires activity. Neuron 17: 1057-1064.
61. MCALLISTER, A. K., L. C. KATZ & D. C. Lo. 1997. Opposing roles for endogenous BDNF and NT-3 in regulating cortical dendritic growth. Neuron 18: 767-778.
62. ZERVAS, M. & S. U. WALKLEY. 1997. Gangliosides and dendritogenesis in cortical development. Society for Neuroscience Abstracts, Vol. 23: 79.